Table 2 Sample characteristics (N=1494)
N | % | |
|---|---|---|
Age | ||
⩽39 years | 96 | 6.4 |
40–59 years | 508 | 34 |
⩾60 years | 890 | 59.6 |
Tumour site | ||
Breast | 166 | 11.1 |
Ovaries | 38 | 2.5 |
Cervix | 93 | 6.2 |
Endometrium | 36 | 2.4 |
Vulva | 12 | 0.8 |
Other pelvic | 8 | 0.5 |
Prostate | 280 | 18.7 |
Bladder | 62 | 4.1 |
Kidneys | 66 | 4.4 |
Testicles | 29 | 1.9 |
Penis | 4 | 0.3 |
Lungs | 53 | 3.5 |
Oesophagus | 34 | 2.3 |
Stomach | 28 | 1.9 |
Pancreas | 39 | 2.6 |
Liver | 50 | 3.3 |
Gallbladder | 24 | 1.6 |
Small intestine | 7 | 0.5 |
Colon | 63 | 4.2 |
Rectum | 107 | 7.2 |
Malignant melanoma | 26 | 1.7 |
Thyroid | 14 | 0.9 |
Tongue | 13 | 0.9 |
Tonsils | 15 | 1.0 |
Oral cavity | 12 | 0.8 |
Pharynx | 45 | 3.0 |
Larynx | 15 | 1.0 |
Brain | 70 | 4.7 |
Eye | 3 | 0.2 |
Sarcoma | 8 | 0.5 |
Haematological | 49 | 3.3 |
Cancer of unknown primary | 8 | 0.5 |
Other | 17 | 1.1 |
Tumour stage (UICC) | ||
0 | 24 | 1.6 |
I | 220 | 14.7 |
II | 290 | 19.4 |
III | 257 | 17.2 |
IV | 141 | 9.4 |
Unknown | 562 | 37.6 |
Tumour progression | ||
Primary cancer | 1144 | 76.6 |
Recurrent disease | 88 | 5.9 |
Metastases | 167 | 11.2 |
Secondary tumour | 49 | 3.3 |
Other | 30 | 2.0 |
Unknown | 16 | 1.1 |
